Cargando…
Corrigendum to: Digoxin use in contemporary heart failure with reduced ejection fraction: An analysis from the Swedish Heart Failure Registry
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084337/ https://www.ncbi.nlm.nih.gov/pubmed/36744617 http://dx.doi.org/10.1093/ehjcvp/pvad010 |
Ejemplares similares
-
Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry
por: Kapelios, Chris J, et al.
Publicado: (2021) -
Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF)
por: Parikh, Riya R, et al.
Publicado: (2022) -
Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction
por: Zhou, Jingmin, et al.
Publicado: (2020) -
Corrigendum to “Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant Capacity”
por: Mancini, Antonio, et al.
Publicado: (2020) -
Corrigendum to: Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models
Publicado: (2022)